Pseudoginsengenin DQ exerts antitumour activity against hypopharyngeal cancer cells by targeting the HIF-1α-GLUT1 pathway
Abstract Background Ginsenosides have been reported to possess a variety of biological activities. Synthesized from the ginsenoside protopanaxadiol (PPD), the octanone pseudoginsengenin DQ (PDQ) may have robust pharmacological effects as a secondary ginsenoside. Nevertheless, its antitumour activity...
Main Authors: | Sanchun Wang, Yu Cai, Qingjie Feng, Jing Gao, Bo Teng |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-07-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12935-021-02080-x |
Similar Items
-
Pharmacokinetic and Metabolism Studies of 12-Riboside-Pseudoginsengenin DQ by UPLC-MS/MS and UPLC-QTOF-MSE
by: Zhenzhou Wang, et al.
Published: (2018-09-01) -
Pseudoginsengenin DQ Exhibits Therapeutic Effects in Cisplatin-Induced Acute Kidney Injury via Sirt1/NF-κB and Caspase Signaling Pathway without Compromising Its Antitumor Activity in Mice
by: Zeng Qi, et al.
Published: (2018-11-01) -
Metabolic Heterogeneity of Cancer Cells: An Interplay between HIF-1, GLUTs, and AMPK
by: Nurbubu T. Moldogazieva, et al.
Published: (2020-04-01) -
The Rho/Rac Guanine Nucleotide Exchange Factor Vav1 Regulates Hif-1α and Glut-1 Expression and Glucose Uptake in the Brain
by: Jaewoo Hong, et al.
Published: (2020-02-01) -
GLUT3 expression in cystic change induced by hypoxia in pituitary adenomas
by: Tao Mei, et al.
Published: (2018-12-01)